Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma (Q33597441)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma |
scientific article |
Statements
1 reference
Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma (English)
1 reference
Fariba Navid
1 reference
Paul M Sondel
1 reference
Raymond Barfield
1 reference
Jim A Allay
1 reference
Jacek Gan
1 reference
Paul Hutson
1 reference
Songwon Seo
1 reference
Kyungmann Kim
1 reference
Jacob Goldberg
1 reference
Jacquelyn A Hank
1 reference
Catherine A Billups
1 reference
Jianrong Wu
1 reference
Wayne L Furman
1 reference
Lisa M McGregor
1 reference
Mario Otto
1 reference
Stephen D Gillies
1 reference
Rupert Handgretinger
1 reference
Victor M Santana
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference